VisIMon - Development of an intelligent system that observes and guarantees continuous bladder irrigatio

• Conditions: Hyperplasia of prostate; Neoplasm of uncertain or unknown behaviour of urinary organs; N40; D41

• Registration Number: DRKS00023647
• Lead Sponsor: niversitätsklinikum Freiburg Department ChirurgieAbteilung für UrologieSektion Urotechnologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Age 18 or older
patients with planned transurethral surgery (TUR-P, TUR-B, HoLEP) and subsequent continuous bladder irrigation
Study protocol VisIMon Version 1 06.08.2020
Written informed consent according to international guidelines and local laws;
Ability to understand and comply with the nature of the trial and trial-related procedures and to comply with them

Exclusion Criteria

Patients not capable of giving consent
Underage patients

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Validation of the data collected via Hb sensor and weight sensors, insensitivity of the of the system to interfering factors

Secondary Outcome Measures

Name	Time	Method
Evaluation of acceptance from the patient perspective